Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 15/20 | 0.40 |
| ▸ | MEN1 | O00255 | 14/20 | 0.40 |
| ▸ | MAPT | P10636 | 14/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 14/20 | 0.40 |
| ▸ | GLA | P06280 | 12/20 | 0.40 |
| ▸ | HPGD | P15428 | 12/20 | 0.40 |
| ▸ | GAA | P10253 | 9/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 9/20 | 0.38 |
| ▸ | CACNA1G | O43497 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 6/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.37 |
| ▸ | ATM | Q13315 | 3/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | CES2 | O00748 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | GFER | P55789 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12994700 | 0.87 | CACNA1G (0.38) | ALDH1A1MEN1MAPTKMT2AGLA | |
| SCHEMBL4132330 | 0.84 | ALDH1A1 (0.40) | ALDH1A1MEN1MAPTKMT2AGLA | |
| SCHEMBL4123873 | 0.83 | HPGD (0.42) | ALDH1A1MEN1MAPTKMT2AGLA | |
| SCHEMBL22859762 | 0.83 | ALDH1A1 (0.36) | ALDH1A1MEN1MAPTKMT2AGLA | |
| SCHEMBL4131065 | 0.81 | ALDH1A1 (0.40) | ALDH1A1MEN1MAPTKMT2AGLA | |
| SCHEMBL12138950 | 0.76 | MEN1 (0.33) | ALDH1A1MEN1MAPTKMT2AGLA | |
| SCHEMBL19139217 | 0.74 | MEN1 (0.44) | ALDH1A1MEN1MAPTKMT2AGLA | |
| SCHEMBL14776961 | 0.71 | MEN1 (0.38) | ALDH1A1MEN1MAPTKMT2AGLA | |
| SCHEMBL4140918 | 0.71 | HPGD (0.42) | ALDH1A1MEN1MAPTKMT2AGLA | |
| SCHEMBL13881931 | 0.70 | MEN1 (0.32) | ALDH1A1MEN1MAPTKMT2AGLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 98 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9006336-B2 | Curable polysiloxane coating composition | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2015-04-14 | — | — | US | claimed |
| EP-2838935-A1 | CURABLE POLYSILOXANE COATING COMPOSITION | 3M Innovative Properties Company (US) | 2015-02-25 | — | — | EP | claimed |
| US-20140378608-A1 | CURABLE POLYSILOXANE COATING COMPOSITION | 3M INNOVATIVE PROPERTIES COMPANY | 2014-12-25 | — | — | US | claimed |
| WO-2013101477-A1 | CURABLE POLYSILOXANE COATING COMPOSITION | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2013-07-04 | — | — | WO | claimed |
| EP-2044013-B1 | PROCESS FOR PRODUCING 2-HYDROXY-4-(METHYLTHIO)BUTYRATE COMPOUNDS AND INTERMEDIATES THEREOF | SUMITOMO CHEMICAL CO (JP) | 2013-05-29 | — | — | EP | claimed |
| US-20090192328-A1 | PROCESS FOR PRODUCING 2-HYDROXY-4-(METHLTHIO)BUTYRATE COMPOUNDS AND INTERMEDIATES THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-07-30 | — | — | US | claimed |
| US-12376484-B2 | Heteroleptic carbene complexes and the use thereof in organic electronics | BASF SE (DE) | 2025-07-29 | — | — | US | disclosed |
| US-12312472-B2 | Binder composition comprising polyamine(s) as well as 1,3-dihydroxyacetone, glycolaldehyde and/or glyceraldehyde for composite articles | BASF SE (DE) | 2025-05-27 | — | — | US | disclosed |
| WO-2025085698-A1 | ABIOTIC CATALYTIC CONVERSION OF CARBON DIOXIDE TO SUGARS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-04-24 | — | — | WO | disclosed |
| CN-118239909-A | Ketone-containing bisfuranyl monomer compound, preparation method thereof, electronic packaging adhesive and application thereof | 中国科学技术大学 | 2024-06-25 | — | — | CN | disclosed |
| US-20240130221-A1 | HETEROLEPTIC CARBENE COMPLEXES AND THE USE THEREOF IN ORGANIC ELECTRONICS | UDC IRELAND LIMITED (IE) | 2024-04-18 | — | — | US | disclosed |
| US-20240052168-A1 | BINDER COMPOSITION COMPRISING POLYAMINE(S) AS WELL AS 1,3 -DIHYDROXYACETONE, GLYCOLALDEHYDE AND/OR GLYCERALDEHYDE FOR COMPOSITE ARTICLES | BASF SE (DE) | 2024-02-15 | — | — | US | disclosed |
| US-11839140-B2 | Metal complexes comprising diazabenzmidazolocarbene ligands and the use thereof in OLEDS | UDC IRELAND LIMITED (IE) | 2023-12-05 | — | — | US | disclosed |
| EP-0772578-B1 | METHOD OF PRODUCING ACYLOINES | BASF AG (DE) | 2001-09-19 | — | — | EP | disclosed |
| EP-0749965-B1 | Process for the preparation of 1,2,4-triazolium salts and 1,2,4-triazoles | BASF AG (DE) | 1999-11-24 | — | — | EP | disclosed |
| US-5840894-A | Preparation of 1,2,4-triazolium salts and 1,2,4-triazolines | BASF AKTIENGESELLSCHAFT (DE) | 1998-11-24 | — | — | US | disclosed |
| US-5831097-A | TRIAZOLIUM SALT REACTIVE CATALYST, ALDEHYDE CONDENSATION | BASF AKTIENGESELLSCHAFT (DE) | 1998-11-03 | — | — | US | disclosed |
| EP-0772578-A1 | METHOD OF PRODUCING ACYLOINES | BAYER AG (DE) | 1997-05-14 | — | — | EP | disclosed |
| EP-0749965-A1 | Process for the preparation of 1,2,4-triazolium salts and 1,2,4-triazoles | BASF AKTIENGESELLSCHAFT (DE) | 1996-12-27 | — | — | EP | disclosed |
| WO-1996002484-A1 | METHOD OF PRODUCING ACYLOINES | BASF AKTIENGESELLSCHAFT (DE) | 1996-02-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12376484-B2 | Heteroleptic carbene complexes and the use thereof in organic electronics | OCIAD2, OCIAD1, CLTB | ALDH1A1 3051/4885MEN1 3474/4885MAPT 100/4885 |
| US-20240130221-A1 | HETEROLEPTIC CARBENE COMPLEXES AND THE USE THEREOF IN ORGANIC ELECTRONICS | OCIAD2, OCIAD1, CLTB | ALDH1A1 3051/4885MEN1 3474/4885MAPT 100/4885 |
| US-20090192328-A1 | PROCESS FOR PRODUCING 2-HYDROXY-4-(METHLTHIO)BUTYRATE COMPOUNDS AND INTERMEDIATES THEREOF | HAO2, BBOX1, HAO1 | ALDH1A1 35/4885MEN1 1652/4885MAPT 2728/4885 |
| US-11839140-B2 | Metal complexes comprising diazabenzmidazolocarbene ligands and the use thereof in OLEDS | OCIAD1, OCIAD2, DRD2 | ALDH1A1 2588/4885MEN1 1374/4885MAPT 893/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.